Abstract
Antagonists of the 5-HT(6) receptor have been shown to improve cognitive function in a wide range of animal models and as such may prove to be attractive agents for the symptomatic treatment of cognitive disorders such as Alzheimer's disease (AD) and schizophrenia. We report herein the identification and SAR around N-(2-aminoalkyl)-1-(arylsulfonyl)indoline-3-carboxamides-a novel chemotype of 5-HT(6) antagonists.
Copyright 2010 Elsevier Ltd. All rights reserved.
MeSH terms
-
Amides / chemistry*
-
Amides / pharmacology
-
Animals
-
Biological Availability
-
Drug Discovery
-
Humans
-
Indoles / chemistry*
-
Indoles / pharmacology
-
Male
-
Microsomes
-
Pharmacokinetics
-
Rats
-
Rats, Wistar
-
Receptors, Serotonin / drug effects*
-
Serotonin Receptor Agonists / chemical synthesis*
-
Serotonin Receptor Agonists / chemistry
-
Structure-Activity Relationship
Substances
-
Amides
-
Indoles
-
Receptors, Serotonin
-
Serotonin Receptor Agonists
-
serotonin 6 receptor
-
indoline